Subscribe: Biotechnology
http://rss.prnewswire.com/industry/bio
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
announced  cancer  company  data  dec prnewswire  dec  market  new  prnewswire  report  research  results  today announced  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Biotechnology

PR Newswire: Biotechnology



Press Releases from PR Newswire about Biotechnology



Published: Sun, 11 Dec 2016 01:10:41 EST

Last Build Date: Fri, 09 Dec 2016 16:15:00 EST

 



Axovant Unveils New Data Analysis Showing Addition of Intepirdine to Standard Therapy May Help People with Alzheimer's Disease Maintain Independence Longer

Fri, 09 Dec 2016 16:15:00 EST

(image) HAMILTON, Bermuda, Dec. 9, 2016 /PRNewswire/ -- Axovant Sciences Ltd. (NYSE: AXON), a leading clinical-stage biopharmaceutical company focused on the treatment of dementia, today announced a new analysis of the data from a Phase 2b trial evaluating treatment with intepirdine (RVT-101),...



Media Files:
http://www.axovant.com




New England Biolabs® Lights The Way With Luna® Universal Kits For Simplified qPCR and RT-qPCR

Fri, 09 Dec 2016 10:43:00 EST

(image) IPSWICH, Mass., Dec. 9, 2016 /PRNewswire/ -- New England Biolabs (NEB®) today announced the launch of its Luna Universal qPCR & RT-qPCR kits, which are optimized for DNA or RNA quantitation from diverse sample sources and target types, and are compatible with a wide range of...



Media Files:
https://photos.prnewswire.com/prnvar/20160907/405111LOGO




Oligonucleotide Synthesis Market Worth 2.20 Billion USD by 2021

Fri, 09 Dec 2016 10:00:00 EST

(image) PUNE, India, December 9, 2016 /PRNewswire/ -- According to a new market research report "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom, Predesigned, Reagent Equipment), Application (Research, PCR, Gene, DNA, NGS, Diagnostic, RNAI), End user...



Media Files:
http://photos.prnewswire.com/prn/20160303/792302




aTyr Pharma to Present at the BMO Prescriptions for Success Healthcare Conference

Fri, 09 Dec 2016 09:00:00 EST

(image) SAN DIEGO, Dec. 9, 2016 /PRNewswire/ -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced that senior management will participate in a fireside chat at...



Media Files:
http://photos.prnewswire.com/prnh/20120809/MM55538LOGO




Biohaven' BHV-0223 is Granted Orphan Drug Designation in the Treatment of Amyotrophic Lateral Sclerosis

Fri, 09 Dec 2016 09:00:00 EST

(image) TORONTO, Dec. 9, 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that Biohaven has issued today the following press release: New Haven, Connecticut (PRWEB) Dec 9, 2016 - Biohaven...



Media Files:
www.portagebiotech.com




China Cord Blood Corporation Announces Results of 2016 Annual General Meeting

Fri, 09 Dec 2016 08:49:00 EST

(image) HONG KONG, Dec. 9, 2016 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2016...



Media Files:
http://www.chinacordbloodcorp.com




12-month Edaravone Clinical Study Data in ALS Presented at the 27th International Symposium on ALS/MND

Fri, 09 Dec 2016 08:45:00 EST

(image) OSAKA, Japan, Dec. 9, 2016 /PRNewswire/ -- Mitsubishi Tanabe Pharma Corporation (Head Office: Osaka; President & Representative Director, CEO: Dr. Masayuki Mitsuka) has presented data that show patients with amyotrophic lateral sclerosis (ALS) given edaravone intravenously in 10-14...



Media Files:
https://www.mt-pharma-america.com




Genomic Health Announces Results from Multiple Oncotype DX® Studies, Reinforcing its Impact in Delivering Precision Medicine to Breast Cancer Patients Around the World

Fri, 09 Dec 2016 08:40:00 EST

(image) REDWOOD CITY, Calif., Dec. 9, 2016 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced results from multiple studies demonstrating the unparalleled value of the Oncotype DX® test in individualizing breast cancer treatment decisions for patients with various stages of the...



Media Files:
http://photos.prnewswire.com/prnh/20130425/SF01493LOGO




New Orthopedic Device Technology Moves From Lab Toward Operating Room With Help From Philadelphia-Based Start-Up OrthoMend Research, Inc.

Fri, 09 Dec 2016 08:37:00 EST

(image) PHILADELPHIA, Dec. 9, 2016 /PRNewswire-USNewswire/ -- A platform of orthopedic device technologies developed by researchers  from Temple University are moving one step closer to becoming viable options for repairing broken bones and orthopedic applications. OrthoMend Research, Inc., a...



Media Files:
http://www.orthomend.com




Label-Free Array Systems Market to be Worth US$1.7 Billion by 2024: Reduced Cost and Turnaround Time to Offer Significant Opportunities, Predicts TMR

Fri, 09 Dec 2016 08:30:00 EST

ALBANY, New York, December 9, 2016 /PRNewswire/ -- The research report by Transparency Market Research states that the top five players in the Global Label-Free Array Systems Market accounted for a share of 62.7% in the overall market in 2015. Players such as Biacore, Agilent Technolog...



ProclaRx Hosts Awareness and Networking Event to Promote the Breakthrough Medical Discovery

Fri, 09 Dec 2016 08:30:00 EST

(image) WOODMERE, Ohio, Dec. 9, 2016 /PRNewswire/ -- On Tuesday, November 29, 2016, ProclaRx, a biotechnology company developing innovative therapeutics for patients suffering from serious bacterial infections, held an awareness and networking event to promote its breakthrough medical discovery....



Media Files:
http://www.proclarx.com




Arvinas Presents Data on Oral Estrogen Receptor PROTAC Degrader at 2016 San Antonio Breast Cancer Symposium

Fri, 09 Dec 2016 08:00:00 EST

(image) NEW HAVEN, Conn., Dec. 9, 2016 /PRNewswire/ -- Arvinas LLC, a private biotechnology company creating a new class of drugs known as PROTACs, which function via targeted protein degradation, today announced that data were presented during an oral presentation at the 2016 San Antonio Breast...



Media Files:
http://www.arvinas.com




Second Genome Announces Appointments in Human Resources, Finance to Support Corporate Growth

Fri, 09 Dec 2016 08:00:00 EST

(image) SOUTH SAN FRANCISCO, Calif., Dec. 9, 2016 /PRNewswire/ -- Second Genome, Inc., a leader in the development of novel medicines through innovative microbiome science, announced today that it has appointed Jim Sjoerdsma as executive vice president of human resources and Brian Dowd as senior...



Media Files:
http://www.secondgenome.com




Global Pharma, Biotech and Diagnostics Option and Evaluation Partnership Terms and Agreements Analysis 2010-2016 - Research and Markets

Fri, 09 Dec 2016 07:10:00 EST

(image) DUBLIN, Dec 9, 2016 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016" report to their offering. This report focuses on option and evaluation...



Media Files:
http://photos.prnewswire.com/prnh/20160330/349511LOGO




Carmentix et l'Université de Melbourne annoncent l'initiative « Découverte des biomarqueurs des naissances prématurées »

Thu, 08 Dec 2016 23:37:00 EST

SINGAPOUR, 9 décembre 2016 /PRNewswire/ -- Carmentix Private Limited (« Carmentix ») et l'Université de Melbourne sont fiers d'annoncer l'initiative « Découverte des biomarqueurs des naissances prématurées ». Cette étude clinique collaborative vise à valider l...



Global Biostimulants Industry

Thu, 08 Dec 2016 19:28:00 EST

(image) LONDON, Dec. 8, 2016 /PRNewswire/ -- This report analyzes the worldwide markets for Biostimulants in US$ by the following Product Segments: Acid Based (Humic, Amino, & Fulvic), Extract Based, and Others. The report also analyzes the Global market by the following Crop Types:...



Media Files:
http://www.reportbuyer.com




Dr. Andre Goy and Cota presented "Impact of Charlson Comorbidity Index (CCI) and Refining the MIPI Index in Mantle Cell Lymphoma" at the 58th American Society of Hematology Annual Meeting & Exposition

Thu, 08 Dec 2016 16:52:00 EST

(image) NEW YORK, Dec. 8, 2016 /PRNewswire/ -- Dr. Andre Goy, Chairman of the John Theurer Cancer Center and board member of Cota, the leading data and technology platform for value-based precision medicine, presented "Impact of Charlson Comorbidity Index (CCI) and Refining the MIPI Index in...



Media Files:
https://photos.prnewswire.com/prnvar/20161129/443604LOGO




Pittsburgh Life Sciences Greenhouse Announces CEO Succession

Thu, 08 Dec 2016 16:03:00 EST

(image) PITTSBURGH, Dec. 8, 2016 /PRNewswire/ -- The Board of Directors of the Pittsburgh Life Sciences Greenhouse (PLSG), Western Pennsylvania's only pure life sciences investment firm, today announced a change in leadership. In accordance with the succession plan developed by the Nominating and...



Media Files:
https://photos.prnewswire.com/prnvar/20161208/447273LOGO




OncoSec Announces First Quarter Financial Results for Fiscal Year 2017

Thu, 08 Dec 2016 16:01:00 EST

(image) SAN DIEGO, Dec. 8, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced financial results for the fiscal first quarter 2017. "We are delivering on our commitment to address an...



Media Files:
http://photos.prnewswire.com/prnh/20120905/LA68078LOGO




Morgan Freeman Joins Stand Up To Cancer And Genentech In New PSA

Thu, 08 Dec 2016 15:00:00 EST

(image) LOS ANGELES and NEW YORK, Dec. 8, 2016 /PRNewswire-USNewswire/ -- Stand Up To Cancer (SU2C) and Genentech, a member of the Roche Group, have collaborated on a new public service announcement (PSA) featuring Academy Award®-winning actor and SU2C Ambassador Morgan Freeman, who also is an exe...



Media Files:
https://photos.prnewswire.com/prnvar/20161208/447231